author-photo

Lorraine A. Chantrill

Garvan Institute of Medical Research

79

Papers

6831

Citations

Citation Trend

Filter By

Papers (51) Sort By

Journal Conference Others

AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer.

2021 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (0)
MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)

2021 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Update on optimal management for pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.

2021 Expert Review of Anticancer Therapy
Show All
- Source
- Cite
- Save
Citations (0)
Australasian Gastro-Intestinal Trials Group (AGITG) MASTERPLAN: Randomized phase II study of modified neoadjuvant FOLFIRINOX alone or in combination with stereotactic radiotherapy (SBRT) for patients with high-risk and locally advanced pancreatic cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia.

2020 Asia-pacific Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
107P Safety and efficacy of trifluridine/tipiracil (FTD/TPI) in previously treated metastatic colorectal cancer (mCRC): Results from the Australian cohort of the phase IIIb, international, open-label, early-access PRECONNECT study

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus

2019 Hpb
Show All
- Source
- Cite
- Save
Citations (13)
BEACON CRC: A randomized, 3-Arm, phase 3 study of Encorafenib (ENCO) and Cetuximab (CETUX) with or without Binimetinib (BINI) versus choice of either Irinotecan or FOLFIRI plus Cetuximab in BRAF V600E-mutant metastatic colorectal cancer

2019 Asia-pacific Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
ROBO2 is a stroma suppressor gene in the pancreas through regulation of TGF-β

2019 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future

2018 Internal Medicine Journal
Show All
- Source
- Cite
- Save
Citations (1)